Our present study is the first to report that ACK1 is involved in regulating the activation of the TLR signaling pathways and mediating inflammation and autoimmunity, and that inhibition of ACK1 activity can significantly attenuate the pathogenesis of inflammatory and autoimmune diseases. The gene discussed is TNK2; the disease is autoimmune disease.